The analyst community exhibits a heightened bullish sentiment about Arcellx following substantial upgrades in next year's revenue and loss forecasts. Although the company's revenue growth is projected to decelerate, it's still anticipated to outpace the industry growth.
$プロクター・アンド・ギャンブル(PG.US)$Downgraded to Hold From Buy at Truist Procter & Gamble Price Target Cut to $155.00/Share From $165.00 by Truist Securities. Roth Capital Upgrades$スナップオン(SNA.US)$to Buy From Neutral, Adjusts Price Target to $298 From $278 Snap-On (SNA) has an average rating of hold and price targets ranging from $190 to $302, according to analysts polled by Capital IQ. Truist Securities Initiates Coverage of$アーセルクス(ACLX.US)$...
QUICK SCALP $ACLX — STOCK PLAY NEED IT TO BREAK OVER: $22.24 key indicator for MORE uptrend $22.45 confirmation uptrend - $22.61 mini breakout - $22.86$アーセルクス(ACLX.US)$
アーセルクスに関するコメント
$Mingteng International(MTEN.US)$ buy
Gear up for AACR24!
⇨ held by 5 biopharma-focused hedge funds! 🔥
$アーセルクス(ACLX.US)$ : Anito-cel (Ph 2)
$アダプティミューン・セラピューティクス(ADAP.US)$ : Afami-cel (PDUFA) ⏳
$バイシクル・セラピューティクス(BCYC.US)$ : BT8009 (Ph 1/2)
$センテッサ・ファーマシューティカルズ(CNTA.US)$ : LB101 (Ph 1/2)
$デイ・ワン・バイオファーマシューティカルズ(DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$フェイト・セラピューティクス(FATE.US)$ : FT576 (Ph 1)
$フュージョン・ファーマシューティカルズ(FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...
The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics
コラムUS Top Rating Updates on 5/18: SNA, TME, PG, ACLX and More
Procter & Gamble Price Target Cut to $155.00/Share From $165.00 by Truist Securities.
Roth Capital Upgrades $スナップオン(SNA.US)$to Buy From Neutral, Adjusts Price Target to $298 From $278
Snap-On (SNA) has an average rating of hold and price targets ranging from $190 to $302, according to analysts polled by Capital IQ.
Truist Securities Initiates Coverage of $アーセルクス(ACLX.US)$ ...
Suspended for news
コラムToday's pre-market stock movers: KR, REV, RACE, PHG and more
• $アケロ・セラピューティクス(AKRO.US)$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $ブライトスパイア・キャピタル(BRSP.US)$ +6.3% (increases dividend)
• $カロバイオス・ファーマシューティカルズ(HGEN.US)$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $アリソン・トランスミッション・ホールディングス(ALSN.US)$ +2.8% (electric hybrid bu...
NEED IT TO BREAK OVER: $22.24
key indicator for MORE uptrend $22.45
confirmation uptrend - $22.61
mini breakout - $22.86 $アーセルクス(ACLX.US)$
まだコメントはありません